Abstract Library

#2943 Risk Stratification of Well-Differentiated Rectal Neuroendocrine Tumors

Introduction: How to screen patients with well-differentiated rectal neuroendocrine tumors (NETs) who had high risk to develop metastatic disease and poor survival was still less cleared.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author:

Authors: Zhang Y, Chen L, Zhang Y, Guan X, Pan Y,

Keywords: rectal neuroendocrine tumors, metastasis, survival,

#2844 Rectal Neuroendocrine Tumor with Chromogranin Expression Is Associated with Aggressive Clinical Behavior and Worse Prognosis

Introduction: Although rectal neuroendocrine tumors (NETs) with L-cell phenotype and small tumor size generally had better clinical behavior, the new 2019 WHO classification classified all rectal NETs are malignant without considering L-cell phenotype and small tumor size. Therefore, identifying biomarkers of rectal NETs is important to stratify the clinical behavior of rectal NETs.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author: Kim J

Authors: Kim J, Kim J, Oh E, Yang D, Hong S,

Keywords: Rectal neuroendocrine tumor, Chromogranin, Immunohistochemistry, Prognosis,

#2823 Peptide Receptor Radionuclide Therapy in Rectal Neuroendocrine Tumours

Introduction: Neuroendocrine tumours (NETs) arising from the rectum are more common in the Asian population. Current treatment options include somatostatin analogues, chemotherapy, and more recently, peptide-receptor radionuclide therapy (PRRT). Peptide receptor radionuclide therapy (PRRT) has been shown to be effective in the treatment of advanced gastroenteropancreatic (GEP) tumours with minimal adverse effects. Studies have also suggested that rectal NETs show good response to PRRT, better than GEP NETs.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author:

Authors: Tham W, Huang H, Tai W, Yan X, Ng C,

Keywords: Neuroendocrine tumours, PRRT,

#2767 Rectal NETs and Rectosigmoid Junction NETs May Need to Be Treated Differently

Introduction: Neuroendocrine tumours (NETs) are heterogeneous, and the incidence of colorectal NETs is rapidly increasing.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author: Cai W

Authors: Cai W, Ge W, Mao J, Hu h,

Keywords: Rectal neuroendocrine tumor, rectosigmoid junction, SEER database, Survival,

#2762 Finding the Risk Factors Associated with Neuroendocrine Tumors of Rectum

Introduction: Neuroendocrine tumors usually exhibits aggressive clinical behaviour and exclusive histopathological features. 60 to 70% of rectal NETs are asymptomatic.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author: Fatima A

Authors: Fatima A, Zai S,

Keywords: colonoscopy, rectal NETs, low HDL-C level,